{
  "id": 19411967,
  "title": "Ultra-low-dose same-target combinations control drug resistance across stages",
  "url": "https://urgent.news/2026/11/10/ultra-low-dose-same-target-combinations-control-drug-resistance",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-10T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.08.764983v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "The emergence of drug resistance continues to limit the long term effectiveness of cancer therapies [1], as tumour cells adapt to therapeutic selective pressure through diverse genetic and non-genetic routes [2,3]. Despite advances in more potent and next generation inhibitors and mechanism based combination therapies [4,5], durable disease control remains difficult to achieve. Here we tested an…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}